After parting ways with its diabetes franchise nearly three years ago, BD is slimming down even further with a plan to divest its diagnostic and biosciences businesses as the company nears the finish ...

BD, a leading global medical technology company, and Frazier Healthcare Partners, a leading private equity firm focused exclusively on the healthcare sector, announced a definitive agreement for BD to ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

BD (Becton, Dickinson and Company) has agreed to combine its biosciences and diagnostic solutions business with Waters Corporation, creating a new life science and diagnostics company. The agreement ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The settlement is confidential but, in its most recent quarterly report, BD disclosed accruals for the hernia product liability claims, plus related legal defense costs, of about $1.7 billion on June ...

Global medtech giant BD announced that it is adding capacity to its US-based footprint for the production of critical medical devices, including syringes, needles, and IV catheters. As part of the ...